Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
Public ClinicalTrials.gov record NCT05648591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-label Safety Study of a 1-year 8 to 24 mg/Day Dose Regimen of Iloperidone (FANAPT®) in Adolescent Patients With Schizophrenia or Bipolar I Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Study identification
- NCT ID
- NCT05648591
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 24, 2023 (Actual)
- Primary completion
- Dec 31, 2028 (Estimated)
- Completion
- Dec 31, 2028 (Estimated)
- Last update posted
- Oct 1, 2026
2023 – 2028
United States locations
- U.S. sites
- 11
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Dothan | Alabama | 36303 | Recruiting |
| Vanda Investigational Site | Little Rock | Arkansas | 72204 | Recruiting |
| Vanda Investigational Site | Denver | Colorado | 80202 | Recruiting |
| Vanda Investigational Site | Atlanta | Georgia | 30318 | Recruiting |
| Vanda Investigational Site | Atlanta | Georgia | 30331 | Recruiting |
| Vanda Investigational Site | Decatur | Georgia | 30030 | Recruiting |
| Vanda Investigational Site | Kinston | North Carolina | 28501 | Recruiting |
| Vanda Investigational Site | Cincinnati | Ohio | 45221 | Recruiting |
| Vanda Investigational Site | Garfield Heights | Ohio | 44125 | Recruiting |
| Vanda Investigational Site | Westlake | Ohio | 44145 | Recruiting |
| Vanda Investigational Site | Everett | Washington | 98201 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05648591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2026 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05648591 live on ClinicalTrials.gov.